MENU
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
argenx SE (ARGX) Earnings Date & Reports
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
ARGX is expected to report earnings to rise 8.20% to $7.92 per share on October 22
Q3'26
Est.
$7.92
Q2'26
Beat
by $0.97
Q1'26
Beat
by $0.07
Q4'25
Beat
by $2.07
Q3'25
Beat
by $0.74
The last earnings report on July 23 showed earnings per share of $7.32, beating the estimate of $6.35. With 190.73K shares outstanding, the current market capitalization sits at 60.12B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
How Do I Prepare a Will?
What if My Long-Term Care Insurance Doesn’t Pay for My Expenses?
What is the Form 6251: Alternative Minimum Tax, Individuals?
How to Trade Moving Averages: The Death Cross?
KBH, FDS, CMC, FDX, CCL, BB, SNX, WOR, MU, PAYX, GIS, NG, NKE, WBA, FIZZ, LNN | Q1 2025 Earnings Preview: June 23-27, 2025
A.I. Advisor
published General Information
General Information
a manufacturer of antibody-based medicines
Industry Biotechnology
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
3522
Web
https://www.argenx.com